Cancer Research Institute - Technology Impact Award
Event details
| Date | 15.11.2025 |
| Category | Conferences - Seminars |
Aim: The CRI Technology Impact Award aims to bridge the gap between conceptual technological innovation and real-world clinical application. The award supports visionary, high-risk/high-reward ideas that could lay the groundwork for a new generation of tools, platforms, and systems capable of overcoming the most critical barriers in the field.
The most competitive applicants will propose innovations that address areas where technological advancement can have the greatest impact on cancer immunotherapy and patient outcomes. Such technologies may include, but are not limited to:
Duration: 2-4 years
Funding: $600,000
Eligibility: Applicants must hold a tenure-track position at a not for profit research center or institution. Clinical cancer immunologists and technology developers are encouraged to collaborate. Co-PIs are eligible and encouraged to apply.
How to Apply: The process for applying for a Tech Impact Grant consists of two parts: a Letter of Intent, and, if invited, a full application (invitations are due mid-February). Letters of intent and associated supporting documents must be submitted electronically through a special submission portal.
Deadline, Letter of Intent: 15 November 2024
Deadline, Full Application: 1 March 2026
Further information
The most competitive applicants will propose innovations that address areas where technological advancement can have the greatest impact on cancer immunotherapy and patient outcomes. Such technologies may include, but are not limited to:
- Computational systems biology approaches to analyze large-scale datasets, develop more accurate models of underlying cellular and molecular networks, with the goal of better explaining and predicting response/resistance to cancer therapy
- Advanced cancer (or molecular) profiling technologies that can be used to identify key barriers to immunotherapy and improve target identification and therapeutic decision-making
- Real-time visualization technologies that allow tracking of molecular and cellular immune responses to treatment in mice or humans
- Complex multicellular culture systems that model interactions between tumors and the immune system and enable therapeutic testing or mechanistic studies
- Novel therapeutic technologies that promise to safely and effectively promote tumor immunity in new ways
Duration: 2-4 years
Funding: $600,000
Eligibility: Applicants must hold a tenure-track position at a not for profit research center or institution. Clinical cancer immunologists and technology developers are encouraged to collaborate. Co-PIs are eligible and encouraged to apply.
How to Apply: The process for applying for a Tech Impact Grant consists of two parts: a Letter of Intent, and, if invited, a full application (invitations are due mid-February). Letters of intent and associated supporting documents must be submitted electronically through a special submission portal.
Deadline, Letter of Intent: 15 November 2024
Deadline, Full Application: 1 March 2026
Further information
- More information about the program is available here; FAQ here
- The application portal can be found here
- For any other questions, please contact the Research Office
Practical information
- General public
- Free